Cross Country Healthcare (CCRN) Tops Q4 EPS by 21c, Offers Q1 Guidance

Cross Country Healthcare (NASDAQ: CCRN) reported Q4 EPS of $1.40, $0.21 better than the analyst estimate of $1.19. Revenue for the quarter came in at $640.7 million versus the consensus estimate of $608.58 million.

GUIDANCE:

Cross Country Healthcare sees Q1 2022 EPS of $1.38-$1.48, versus the consensus of $0.63. Cross Country Healthcare sees Q1 2022 revenue of $740-750 million, versus the consensus of $478.9 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c